XCUR
Exicure Inc (XCUR)
Healthcare • NASDAQ • $1.08-3.56%
Key Fundamentals
- Symbol
- XCUR
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $1.08
- Daily Change
- -3.56%
- Market Cap
- $7.33M
- Trailing P/E
- N/A
- Forward P/E
- -1.45
- 52W High
- $9.48
- 52W Low
- $0.94
- Analyst Target
- N/A
- Dividend Yield
- 0.00%
- Beta
- 3.64
About Exicure Inc
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
Company websiteResearch XCUR on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.